A nationwide population-based prospective study of cirrhosis in Iceland

dc.contributor.authorOlafsson, Sigurdur
dc.contributor.authorRögnvaldsson, Sigurjon
dc.contributor.authorBergmann, Ottar M.
dc.contributor.authorJonasson, Jon G.
dc.contributor.authorBenitez Hernandez, Ubaldo
dc.contributor.authorBjörnsson, Einar S.
dc.contributor.departmentFaculty of Medicine
dc.contributor.departmentFaculty of Life and Environmental Sciences
dc.date.accessioned2025-11-20T08:21:03Z
dc.date.available2025-11-20T08:21:03Z
dc.date.issued2021-06-01
dc.description© 2021 The Author(s).en
dc.description.abstractBackground & Aims: The incidence of cirrhosis in Iceland has been the lowest in the world with only 3 cases per 100,000 inhabitants. Alcohol consumption has almost doubled in Iceland from 1980 to 2016. Obesity has also risen and hepatitis C virus has spread among people who inject drugs in Iceland. The aim of this study was to evaluate the effects of these risk factors on the incidence and aetiology of cirrhosis in Iceland. Methods: The study included all patients diagnosed with cirrhosis for the first time during 2010–2015. Diagnosis was based on liver histology or 2 of 4 criteria: cirrhosis on imaging, ascites, varices, and/or elevated INR. Results: Overall, 157 patients were diagnosed, 105 (67%) males, mean age 61 years. The overall incidence was 9.7 cases per 100,000 inhabitants annually. Alcohol was the only underlying cause in 48/157 (31%), non-alcoholic fatty liver disease (NAFLD) in 34/157(22%), and alcohol and hepatitis C together in 23/157(15%) were the most common causes. Only 6% of patients had an unknown cause of cirrhosis. Upon diagnosis, the median model for end-stage liver disease score was 11 (IQR 8–15), 53% were of Child-Pugh class A whereas 61 (39%) had ascites, 11% encephalopathy, and 8% variceal bleeding. In all, 25% of deaths were from HCC and 25% from liver failure. Conclusion: A major increase in incidence of cirrhosis has occurred in Iceland associated with increases in alcohol consumption, obesity, and hepatitis C. In a high proportion NAFLD was the aetiology and very few had unknown cause of cirrhosis. The highest death rate was from HCC. Lay summary: In a nationwide population-based study from Iceland, including all patients diagnosed with cirrhosis of the liver over a period of 5 years, we found the incidence of new cases had increased 3-fold compared with a previous study 20 years ago. The increase is attributable to increased alcohol consumption, an epidemic of diabetes and obesity, and infection with the hepatitis C virus. Furthermore, we found that with thorough investigations, a specific cause for cirrhosis could be found in 94% of patients. Patients with cirrhosis frequently die of liver cancer and other complications related to their liver disease.en
dc.description.versionPeer revieweden
dc.format.extent339850
dc.format.extent100282-Skorpulifur
dc.identifier.citationOlafsson, S, Rögnvaldsson, S, Bergmann, O M, Jonasson, J G, Benitez Hernandez, U & Björnsson, E S 2021, 'A nationwide population-based prospective study of cirrhosis in Iceland', JHEP Reports, vol. 3, no. 3, 100282, pp. 100282-Skorpulifur. https://doi.org/10.1016/j.jhepr.2021.100282en
dc.identifier.doi10.1016/j.jhepr.2021.100282
dc.identifier.issn2589-5559
dc.identifier.other37678563
dc.identifier.other88c6b1e7-b2e5-408f-8444-805ae3f89547
dc.identifier.other85106227815
dc.identifier.other34041467
dc.identifier.otherresearchoutputwizard: hdl.handle.net/2336/621880
dc.identifier.otherunpaywall: 10.1016/j.jhepr.2021.100282
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6301
dc.language.isoen
dc.relation.ispartofseriesJHEP Reports; 3(3)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85106227815en
dc.relation.urlhttps://www.sciencedirect.com/science/article/pii/S2589555921000586?via%3Dihuben
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141932/en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectAetiology of cirrhosisen
dc.subjectAlcoholen
dc.subjectCirrhosisen
dc.subjectHepatitis Cen
dc.subjectIncidence of cirrhosisen
dc.subjectNAFLDen
dc.subjectAIH, autoimmune hepatitisen
dc.subjectALD, alcoholic liver diseaseen
dc.subjectCIF, cumulative incidence functionen
dc.subjectCRR, competing-risks regressionen
dc.subjectHCC, hepatocellular carcinomaen
dc.subjectMELD, model for end-stage liver diseaseen
dc.subjectNAFLD, non-alcoholic fatty liver diseaseen
dc.subjectNALD, non-alcoholic liver diseaseen
dc.subjectNASH, non-alcoholic steatohepatitisen
dc.subjectPBC, primary biliary cirrhosisen
dc.subjectPSC, primary sclerosing cholangitisen
dc.subjectSHRs, subhazard ratiosen
dc.subjectLiver Cirrhosisen
dc.subjectAIH, autoimmune hepatitisen
dc.subjectALD, alcoholic liver diseaseen
dc.subjectAetiology of cirrhosisen
dc.subjectAlcoholen
dc.subjectCIF, cumulative incidence functionen
dc.subjectCRR, competing-risks regressionen
dc.subjectCirrhosisen
dc.subjectHCC, hepatocellular carcinomaen
dc.subjectHepatitis Cen
dc.subjectIncidence of cirrhosisen
dc.subjectMELD, model for end-stage liver diseaseen
dc.subjectNAFLDen
dc.subjectNAFLD, non-alcoholic fatty liver diseaseen
dc.subjectNALD, non-alcoholic liver diseaseen
dc.subjectNASH, non-alcoholic steatohepatitisen
dc.subjectPBC, primary biliary cirrhosisen
dc.subjectPSC, primary sclerosing cholangitisen
dc.subjectSHRs, subhazard ratiosen
dc.subjectLiver Cirrhosisen
dc.subjectImmunology and Allergyen
dc.subjectInternal Medicineen
dc.subjectHepatologyen
dc.subjectGastroenterologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleA nationwide population-based prospective study of cirrhosis in Icelanden
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
A_nationwide_....pdf
Stærð:
331.88 KB
Snið:
Adobe Portable Document Format

Undirflokkur